CIVALLERO, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.057
AS - Asia 1.726
EU - Europa 1.527
SA - Sud America 257
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 54
OC - Oceania 4
Totale 7.684
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.989
SG - Singapore 521
CN - Cina 460
GB - Regno Unito 435
IT - Italia 355
VN - Vietnam 205
HK - Hong Kong 203
BR - Brasile 181
SE - Svezia 154
DE - Germania 130
RU - Federazione Russa 86
FI - Finlandia 82
BD - Bangladesh 77
FR - Francia 65
UA - Ucraina 65
TR - Turchia 51
KR - Corea 36
CA - Canada 34
IN - India 32
ID - Indonesia 28
IE - Irlanda 28
BG - Bulgaria 24
AR - Argentina 22
JP - Giappone 21
MA - Marocco 19
BE - Belgio 18
NL - Olanda 18
MX - Messico 17
IQ - Iraq 16
ZA - Sudafrica 16
EC - Ecuador 14
MY - Malesia 12
CL - Cile 10
PE - Perù 9
PK - Pakistan 9
AT - Austria 8
EG - Egitto 7
LB - Libano 7
LT - Lituania 7
PL - Polonia 7
SA - Arabia Saudita 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
ES - Italia 6
JO - Giordania 5
ET - Etiopia 4
JM - Giamaica 4
PH - Filippine 4
PT - Portogallo 4
UY - Uruguay 4
AU - Australia 3
BO - Bolivia 3
CO - Colombia 3
IR - Iran 3
KE - Kenya 3
NI - Nicaragua 3
PR - Porto Rico 3
PY - Paraguay 3
RO - Romania 3
RS - Serbia 3
TN - Tunisia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
KZ - Kazakistan 2
MK - Macedonia 2
NO - Norvegia 2
QA - Qatar 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AM - Armenia 1
BF - Burkina Faso 1
BS - Bahamas 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
Totale 7.624
Salva come PNG Salva come JPEG
Città #
Ashburn 531
Fairfield 375
Santa Clara 354
Singapore 329
Southend 304
Chandler 259
Woodbridge 236
Hong Kong 200
San Jose 187
Houston 164
Ann Arbor 130
Seattle 123
Cambridge 117
Nyköping 109
Wilmington 104
Beijing 89
Jacksonville 84
Hefei 82
London 80
Dearborn 78
New York 64
Council Bluffs 62
Helsinki 61
Modena 59
Ho Chi Minh City 58
Los Angeles 58
The Dalles 58
Hanoi 54
Chicago 40
San Diego 40
Milan 39
Seoul 36
Frankfurt am Main 31
Dallas 28
Dublin 28
Izmir 27
Princeton 25
Moscow 24
Sofia 24
Fremont 22
Jakarta 22
Lauterbourg 22
Munich 22
Shanghai 21
Eugene 19
São Paulo 19
Brussels 18
Salt Lake City 18
Buffalo 17
Casablanca 16
Cologno Monzese 16
Norwalk 12
Tokyo 12
Atlanta 11
Naples 11
Des Moines 10
Orem 10
Pisa 10
Columbus 9
Johannesburg 9
Miami 9
Montreal 9
Phoenix 9
San Francisco 9
San Giuliano Milanese 9
Boardman 8
Bremen 8
Falls Church 8
Lviv 8
Rome 8
Toronto 8
Amsterdam 7
Brusaporto 7
Chongqing 7
Da Nang 7
Haiphong 7
Lima 7
Nuremberg 7
Parma 7
Redondo Beach 7
Bologna 6
Boston 6
Changsha 6
Dong Ket 6
Guangzhou 6
Quito 6
Redwood City 6
Baghdad 5
Brasília 5
Brooklyn 5
Campinas 5
Caracas 5
Contagem 5
Kuala Lumpur 5
Lappeenranta 5
Latina 5
Mexico City 5
Ottawa 5
Rio de Janeiro 5
Tampa 5
Totale 5.340
Salva come PNG Salva come JPEG
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 392
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 374
Activity of BKM120 and BEZ235 against lymphoma cells 373
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 369
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 349
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 337
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 309
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 294
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 292
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 292
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 288
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 283
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 280
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 278
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 269
Long-term outcome of peripheral T-cell lymphomas: Ten-year follow-up of the International Prospective T-cell Project 268
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 257
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 256
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 251
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 243
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project 237
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 236
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 211
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project 205
COVID-related disruption in mammographic screening: a year later. 181
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply 168
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network 155
The Value and relevance of T-cell lymphoma registries 151
Time to next treatment to evaluate the therapeutic sequence after first- or second-line CDK4/6 inhibitors of hormone receptor-positive, HER2-negative advanced breast cancer in Italy: a retrospective/prospective observational trial GOIRC-04-2019 62
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study. 16
Preparing real-world data through common data model harmonization of cancer patient records in the COMNet platform at the Modena Oncology Center. 8
Totale 7.684
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022555 36 29 63 29 9 64 36 22 44 46 107 70
2022/2023648 74 114 44 66 43 95 7 57 88 7 25 28
2023/2024421 18 24 18 50 82 34 43 47 5 17 48 35
2024/20251.230 50 11 36 103 233 179 96 68 120 43 102 189
2025/20262.581 176 84 165 227 323 188 343 145 274 251 261 144
2026/2027170 170 0 0 0 0 0 0 0 0 0 0 0
Totale 7.684